NCT03527667 is a NA clinical trial of Financial incentives in Smoking Cessation, sponsored by University of Oklahoma.

Who is sponsoring NCT03527667?

NCT03527667 is sponsored by University of Oklahoma.

What drugs are being tested in NCT03527667?

Interventions in NCT03527667: Financial incentives.

What condition does NCT03527667 study?

NCT03527667 studies Smoking Cessation, Diabetes Mellitus, Type 2.

Is NCT03527667 still recruiting?

NCT03527667 is currently completed. Last updated 6 December 2019.

Last reviewed 2019-12-06 · How we verify

NCT03527667

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incentivized Smoking Cessation for Diabetics

Completed NA Last updated 6 December 2019

What this trial tests

NA trial testing Financial incentives in Smoking Cessation in 19 participants. Completed in 30 June 2019.

Timeline

22 June 2018

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	University of Oklahoma
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	19
Start date	22 June 2018
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	2 locations across United Kingdom, United States

Drugs / interventions tested

Financial incentives

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

University of Oklahoma

Who can join

Adults 18 to 75, any sex, with Smoking Cessation or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study aims to test the feasibility of providing incentives to patients with T2D contingent on remote biochemical verification using a smartphone carbon monoxide (CO) monitor. The investigators will use an ecological momentary assessment (EMA) smartphone application and CO sensor to monitor urges to smoke, stressors, smoking behaviors, and to validate continuous abstinence throughout the intervention. Two different contingency management structures will be explored to investigate the length of time incentives need to be offered.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Contingency management for smoking cessation among individuals with type 2 diabetes: protocol for a multi-center randomized controlled feasibility trial.
Martinez SA, Quaife SL, Hasan A, McMillan KA, et al · · 2020 · cited 1× · PMID 32537238 · DOI 10.1186/s40814-020-00629-7

Verify or expand the search:

Other trials of Financial incentives

Trials testing the same drug.

NCT06288711 — Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD · NA · recruiting
NCT05322044 — Financial Incentives to Improve Asthma · NA · completed
NCT04902326 — Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change) · NA · completed
NCT04917926 — Behavioural Economics-based Incentives in Adults With Type 2 Diabetes (BET2) · NA · completed
NCT04445662 — Financial Incentives for Homeless Smokers: A Community-based RCT · NA · completed

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other University of Oklahoma trials

Trials by the same sponsor.

NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
NCT07494773 — Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection · Phase 1, PHASE2 · not yet recruiting
NCT07014605 — Smoking Cessation Program for Lao People With HIV · NA · not yet recruiting
NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03527667 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oklahoma
Last refreshed: 6 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03527667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing